Is MDS Cancer? Navigating Your MDS Diagnosis image

Is MDS Cancer? Navigating Your MDS Diagnosis

Aug 24, 2023
01:00PM - 02:00PM MDT
Online Event
Overview

Is MDS Cancer? Dr. Swoboda, an MDS specialist out of Tampa, FL,  will help answer this question. He’ll discuss what an MDS diagnosis looks like, why there is still some lingering discussion on whether MDS is cancer or pre-cancer, and some of the defining characteristics of MDS. 
 

Agenda
1:00 PM
Introduction
Mary Arnett

Mary introduces the agenda for the event and featured speaker David Swoboda, MD.

1:05 PM
Presentation
David Swoboda, MD

Dr. Swoboda answers the question "Is MDS cancer?" He will discuss what an MDS diagnosis looks like and why there is still debate on whether MDS is cancer or pre-cancer.

1:40 PM
Questions and Answers
Audience

Type your questions in the chat and Dr. Swoboda will answer them! 

 
Speakers & Moderators
Healthtree contact Mary Arnett

Mary Arnett

Mary joined HealthTree as the HealthTree for MDS Program Manager in 2022. She is passionate about giving power to patients through knowledge and health education. If she can help one patient feel more confident participating in discussions with their healthcare team and making treatment decisions, she will feel like she has succeeded. When she isn't advocating for MDS patients, she loves being an aunt, attending concerts, and experimenting with new recipes in the kitchen.
Healthtree contact David Swoboda, MD

David Swoboda, MD

David Swoboda, M.D. is a member of the Hematologic Malignancies Program at Tampa General Hospital Cancer Institute and Assistant Professor at the University of South Florida College of Medicine. Prior to joining TGH, Dr. Swoboda served as the chief hematology/oncology fellow at Moffitt Cancer Center and chief resident at Georgetown University Hospital He is actively involved in the care of patients with acute leukemias and myelodysplastic syndromes (MDS) in addition to serving as principal investigator on multiple clinical trials in these diseases. Dr. Swoboda’s research focuses on the genetic drivers and inflammatory significant of myeloid malignancies. He has presented his work at numerous national conferences and has several first author publications in top-tier journals including Leukemia and American Journal of Hematology.